[参考文献]
[1]Shimizu M,Saitoh Y,Itoh H. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and m alignant human pancreatic tissues[J]. Hum Pathol,1990,21(6):607-612.
[2]Gorji H,Shahbazi N,Habibollahi P,et al.The glutathione-S-transferase P1 polymorphisms correlates with changes in expression of TP53 tumor suppressor in cutaneous basal cell carcinoma[J].J Dermatol Sci,2009,56(3):208-210.
[3]Adamkov M,Halasova E,Rajcani J,et al. Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas[J]. Med Sci Monit,2011,17(3):74-80.
[4]Ansarin H,Daliri M,Soltani-Arabshahi R. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma[J]. Eur J Dermatol,2006,16(5):543-547.
[5]Weissman AM.Themes and variations on ubiquitylation[J].Nat Rev Mol Cell Biol, 2001,2(3):169-178.
[6]Momand J,Zambetti GP,Olson DC,et al.The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation[J].Cell,1992,69(7):1237-1245.
[7]Cho HS,Park EJ,Kim CW,et al.Immunohistochemical Study of p53 and MDM2 Expression on the Epithelial Tumors of the Skin[J]. Korean J Dermatol,2007,45(6):534-540.
[8]Almquist LM,Karagas MR,Christensen BC,et al.The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer[J].Carcinogenesis,2011,32(3):327-330.
 

(责任编辑：南粤论文中心)转贴于南粤论文中心: http://www.nylw.net(南粤论文中心__代写代发论文_毕业论文带写_广州职称论文代发_广州论文网）